心源性休克

xīn yuán xìnɡ xiū kè
  • cardiogenic shock
心源性休克心源性休克
  1. 入院时即发生心源性休克的患者中的急诊血运重建:来自SHOCK试验和登记的报道

    Emergency revascularization in patients with cardiogenic shock on admission : A report from the SHOCK trial and registry

  2. 吸烟、糖尿病、血脂异常、家族史,恶性心律失常、心源性休克、病死率及冠状动脉狭窄程度之间的差异无统计学意义(P>0.05)。

    Smoking , diabetes , dyslipidemia , family history of malignant arrhythmia , cardiogenic shock , mortality and coronary artery stenosis no significant difference between ( P > 0.05 ) .

  3. 老年AMI并心源性休克临床成功率25%。

    The successful rate of elderly AMI patients complicated by cardiac shock was 25 % .

  4. 结论急诊PCI是治疗急性心肌梗死合并心源性休克的有效方法。

    Conclusion Emegency PCI remains an effective way to treat patients with cardiogenic shock followed by acute myocardial infarction .

  5. 对ICU病房的125例休克病人进行回顾性分析,对心源性休克、低容量性休克、分布性休克和梗阻性休克病人进行比较。

    One hundred and twenty-five ICU patients with shock in the recent 10 years were analyzed retrospectively .

  6. 采用麻醉猫实验性心力衰竭和心源性休克的模型观察了抗心衰Ⅱ号口服液(ACⅡ)的作用。

    The effect of " anti-heart-failure ⅱ oral liquid " ( AC ⅱ) on experimental models of heart failure and cardiogenic shock in anesthetized cat was studied .

  7. 结论左主干闭塞导致的急性心肌梗死患者出现心源性休克的发生率较高,且即使成功地施行了PCI治疗,也有较高的病死率。

    Conclusion Patients presenting with AMI caused by acute left main coronary artery occlusion and cardiogenic shock have poor survival regardless of primary PCI .

  8. 比较各组患者肌酸激酶心型同工酶(CKMB)峰值、射血分数、恶性心律失常发生率、心源性休克发生率及病死率。

    Peak CK MB , ejective fraction , incidence of malignant arrhythmia and cardiogenic shock , mortality in four groups were compared .

  9. 人参皂苷Rg2对麻醉犬急性心源性休克血流动力学和氧代谢的影响

    Effects of ginsenoside Rg_2 on hemodynamics and oxygen metabolism in narco-canine with acute cardiogenic shock

  10. 20-(S)和20-(R)人参皂苷Rg2对心源性休克犬血流动力学和血氧含量的影响

    Effect of 20 - ( S ) and 20 - ( R ) ginsenoside Rg_2 on hemodynamics and blood oxygen content of cardiogenic shock canine

  11. 严重心律失常,心源性休克和梗塞扩展在HT组略多(P>0.05)。

    Severe arrythmia , cardiogenic shock and infarction extension in HT group were slightly more than those in NHT group ( P > 0.05 ) .

  12. 合并心源性休克的MOFE患者死亡率为60%;

    The mortality for patients with cardiogenic shock and MOFE was60 % .

  13. 方法对12例心脏手术后并发心源性休克及低心排的患者应用IABP治疗。

    Methods Twelve patients with cardiogenic shock or low cardiac output syndrome after heart surgery were treated with IABP .

  14. 尤对AMI合并心源性休克患者,不仅能明显降低死亡率,挽救生命,而且成功率高,疗效显著,恢复快,可作为AMI首选治疗方法。

    It has specific role in patients with AMI complicated by cardiogenic shock that emergent stenting can not only obviously reduce , but also have high successful rate and notable effect .

  15. 结论合并左心衰竭、心源性休克的高危AMI患者,及时行IABP支持下直接PCI,可明显降低死亡率,改善心脏功能。

    Conclusion The combination of early IABP support and successful PCI can improve survival rate and heart function in AMI patients complicated with pump failure or cardiogenic shock .

  16. 目的:探讨床旁主动脉内球囊反搏术(IABP)辅助救治急性冠脉综合征(ACS)并发心源性休克(CS)的可行性。

    AIM : To investigate the feasibility of bedside application of intra aortic balloon pump ( IABP ) in patients with acute coronary syndrome complicated with cardiogenic shock .

  17. 无胸痛ACS缺乏典型心前区疼痛,常伴有心律失常、心衰、心源性休克、脑血管病等并发症;

    There was no typical chest pain in no-pain ACS patients , and these patients had complications such as cardiac arrhythmias , heart failure , cardiogenic shock , cerebrovascular disease .

  18. 对大多数非心源性休克或TIA的患者,推荐避免长期合用阿司匹林和氯吡格雷(1B级)。

    In most patients with a noncardioembolic stroke or transient ischemic attack , we recommend avoiding long-term use of the combination of aspirin and clopidogrel ( Grade1B ) .

  19. 对心电图QRS积分值、心肌酶峰值、左室射血分数、心源性休克、室壁瘤形成及短期病死率进行比较。

    QRS score , serum cardiac enzymes , left ventricle ejection fraction ( LVEF ), left ventricular aneurysm and mortality within one month of hospitalization were compared between the two groups .

  20. 目的:小结主动脉气囊反搏术(IABP)在冠状动脉支架术围手术期合并严重心源性休克患者中的应用结果。

    Objective : To present the following up result of intraaortic balloon counterpulsation ( IABP ) for patients with cardiogenic shock during periprocedural coronary stenting .

  21. 目的对采用主动脉内球囊反搏(IABP)治疗的心源性休克和心脏破裂病人的住院死亡情况进行回顾性分析。

    Objective An analysis was made of the death of patients with cardiogenic shock and cardiac rupture treated by intra-aortic balloon pump ( IABP ) .

  22. 结论对AMI合并心源性休克患者尽早进行IABP治疗具有明显的循环支持疗效,可以为下一步的治疗争取时间并能明显减少并发症、降低病死率。

    Conclusions The early use of IABP in patients with cardiogenic shock after AMI can improve survival rate and reduce complications , and gain valuable time to prepare for next treatment .

  23. IRA再通率低(7.69%对67.19%),P<0.001;发生心功能不全、恶性心律失常、心源性休克等并发症多(44.23%对29.69%),P<0.01;

    Complications including cardiac functional insufficiency , severe arrhythmia and cardiogenic shock were more than those of CPMI group ( 44.23 % vs 29.69 % , P < 0.01 );

  24. 目的:研究人参皂苷Rg2(ginsenoside,Rg2)对急性心源性休克犬心肌的保护作用。

    Objective : To investigate the effect of Rg 2 on oxygen metabolism of dog with acute cardiogenic shock and ultrastructure of myocyte .

  25. 采用麻醉开胸犬,结扎冠状动脉左前降支(LAD),复制犬急性心源性休克模型,测定心肌缺血程度(∑ST)和心肌缺血范围(NST),梗死面积及血液流变学变化。

    The degree and range of myocardial ischemia , myocardial infarction size and the changes of the hemorrheology were determined by using the acute cardiogenic shock models of ligation of LAD in the anaesthetized open-chest dogs .

  26. 目前对APH循环衰竭的机制及心源性休克的治疗尚缺乏系统、全面的研究。

    The mechanisms of circulatory failure and treatments of cardiogenic shock secondary to acute pulmonary hypertension ( APH ) have not been systematically investigated .

  27. 在用药后30-180分钟,参附+小剂量多巴胺组能够明显升高心源性休克犬的MAP、LVSP、±dp/dtmax,降低LVEDP,对心率无明显影响。

    LVEDP decreased . HR has not changed . 3 . From 30 to 180 minutes of treatment , MAP , LVSP and ± dp / dtmax increased significantly in shenfu injection combined with DA group .

  28. 结论:MI患者PCI即刻疗效好,远期无事件存活率52.7%,AMI伴多支病变或心源性休克是术后早期死亡的主要原因。

    CONCLUSION : PCI achieves satisfactory immediate result in myocardial infarction patients and the long term rate of event free survival is 52.7 % . The main factors of mortality at early stage are acute myocardial infarction accompanied with triper vessel disease or cardiac shock .

  29. 结论:PDS可减轻心肌缺血程度和缺血范围,缩小心肌梗死面积,降低全血黏度和红细胞压积,对急性心源性休克犬具有保护作用。

    Conclusion PDS can decrease the degree and range of myocardial ischemia , myocardial infarction size , the whole blood viscosity and HCT in acute cardiogenic shock dogs . PDS has protective effects on acute cardiogenic shock in dogs .

  30. 方法对心源性休克和心脏破裂的28例病人,均安装IABP,其中20例进行了冠状动脉造影,13例接受了冠状动脉成形术(PTCA)、冠脉旁路移植术(CABG)或心脏外科手术。

    Methods 28 patients were all installed with IABP . 20 patients underwent coronary angiography and 13 patients were treated with PTCA , coronary angioplasty and / or coronary artery bypass grafting ( CABG ) and cardiac surgery .